As the patient, you’re our priority at Janssen, and an ‘expert by experience’. We understand your need for high-quality treatments and services, as well as your desire for knowledge so that you feel empowered and in control of your healthcare. Find out more about how we collaborate with patients and patient advocacy groups, and how we can help you deal with the challenges that disease presents.
Corporate Reputation of Pharma in 2021 Survey
Janssen was ranked in the top three big pharma companies in The Corporate Reputation of Pharma in 2021 survey. The survey collected the opinions of 2,150 patient groups between November 2021-February 2022, and gauged their opinions on the performance of the pharmaceutical industry during 2021. The positivity of 2021’s patient groups looks largely driven by the pharma industry’s response to the Covid-19 pandemic, with up to 76% of patient groups stating that pharma was “Very effective” or “Effective” at providing support to patients during the pandemic. In addition, the 2021 figure places the pharmaceutical industry ahead of all other healthcare stakeholders for corporate reputation for the first time in the 11 years that the pharma industry’s reputation has been tracked from this patient perspective.
Patients are at the heart of what we do.
Your wellbeing is the reason we come to work each day.
Janssen is fully committed to providing high-quality products and services to healthcare professionals, patients, carers and their families. Simply put, we always place the needs and wellbeing of the people we serve first.More about JAnssen
We work for you, but also with you
Patients have always been at the centre of what we do. However, your role as a patient is changing, as patients become more involved, educated and engaged in their healthcare.
At Janssen, we’re adapting to this change by engaging directly with patients and caregivers to develop solutions that better meet needs, improve outcomes, and are available to patients sooner.
We define patient engagement as partnering with patients and caregivers, and interacting directly with them throughout the product lifecycle. This accelerates research and develops patient-inspired innovation and solutions beyond the product.
Our strategy features four pillars:
Differentiated treatments that lead to better outcomes by acting on the patient’s perspective early and across the lifecycle
Inclusion of the patient’s voice in clinical trial protocols to improve patient experience and accelerate research
Collaboration with patients to develop tailored solutions to empower people to manage their disease
Shaping regulatory policies and the field of patient engagement to enhance the patient’s voice globally
The Johnson & Johnson Credo, created over 75 years ago, continues to define our values and behaviours, and encapsulates our deep commitment towards patients. We believe our first responsibility is to the patients, doctors and nurses, to mothers and fathers and all others who use our products and services.our credo